M. Gutniak

4.9k total citations · 2 hit papers
44 papers, 4.0k citations indexed

About

M. Gutniak is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, M. Gutniak has authored 44 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Surgery and 12 papers in Physiology. Recurrent topics in M. Gutniak's work include Diabetes Treatment and Management (22 papers), Pancreatic function and diabetes (12 papers) and Diet and metabolism studies (10 papers). M. Gutniak is often cited by papers focused on Diabetes Treatment and Management (22 papers), Pancreatic function and diabetes (12 papers) and Diet and metabolism studies (10 papers). M. Gutniak collaborates with scholars based in Sweden, Denmark and United Kingdom. M. Gutniak's co-authors include Jens J. Holst, Suad Efendić, Bo Åhrén, Per M. Hellström, Cathrine Ørskov, Anders Thorell, Erik Näslund, Valdemar Grill, Thomas Nyström and Åke Sjöholm and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

M. Gutniak

43 papers receiving 3.9k citations

Hit Papers

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)... 1992 2026 2003 2014 1992 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus
    1992 725 citations M. Gutniak, Cathrine Ørskov et al. New England Journal of Medicine profile →
  2. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
    2004 561 citations Thomas Nyström, M. Gutniak et al. American Journal of Physiology-Endocrinology and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Gutniak Sweden 27 2.6k 1.7k 968 915 562 44 4.0k
John W. Ensinck United States 29 1.4k 0.5× 1.5k 0.9× 982 1.0× 757 0.8× 248 0.4× 65 3.4k
Ole Schmitz Denmark 29 2.3k 0.9× 1.5k 0.9× 1.5k 1.6× 751 0.8× 342 0.6× 57 3.6k
Julie A. Lovshin Canada 25 1.7k 0.6× 790 0.5× 672 0.7× 373 0.4× 310 0.6× 58 2.5k
Simon J. Fisher United States 32 1.2k 0.5× 972 0.6× 1.2k 1.2× 1.1k 1.2× 303 0.5× 86 3.4k
F. P. Alford Australia 36 2.0k 0.8× 722 0.4× 700 0.7× 1.0k 1.1× 454 0.8× 118 3.5k
Erik Frandsen Denmark 30 1.0k 0.4× 582 0.3× 619 0.6× 414 0.5× 616 1.1× 69 2.5k
G. Ahlborg Sweden 33 512 0.2× 1.1k 0.7× 1.1k 1.2× 2.1k 2.3× 695 1.2× 61 4.4k
Christopher J. Kenyon United Kingdom 31 2.4k 0.9× 528 0.3× 754 0.8× 619 0.7× 486 0.9× 90 3.7k
J. M. Burrin United Kingdom 26 1.1k 0.4× 663 0.4× 492 0.5× 494 0.5× 324 0.6× 67 2.6k
Anna M. Eisentraut United States 22 2.0k 0.8× 1.7k 1.0× 853 0.9× 804 0.9× 84 0.1× 29 3.5k

Countries citing papers authored by M. Gutniak

Since Specialization
Citations

This map shows the geographic impact of M. Gutniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gutniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gutniak more than expected).

Fields of papers citing papers by M. Gutniak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gutniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gutniak. The network helps show where M. Gutniak may publish in the future.

Co-authorship network of co-authors of M. Gutniak

This figure shows the co-authorship network connecting the top 25 collaborators of M. Gutniak. A scholar is included among the top collaborators of M. Gutniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Gutniak. M. Gutniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nyström, Thomas, M. Gutniak, Qimin Zhang, et al.. (2004). Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. American Journal of Physiology-Endocrinology and Metabolism. 287(6). E1209–E1215. 561 indexed citations breakdown →
2.
Näslund, Erik, N A King, N. Adner, et al.. (2004). Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects. British Journal Of Nutrition. 91(3). 439–446. 9 indexed citations
3.
Ehlers, Mario R., Klas Malmberg, Gunnar Ronquist, et al.. (2003). Glucagon-like peptide-1 (7–36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium. Peptides. 24(4). 569–578. 84 indexed citations
4.
Gutniak, M., Johan Svartberg, Per M. Hellström, et al.. (2001). Antidiabetogenic action of glucagon‐like peptide‐1 related to administration relative to meal intake in subjects with type 2 diabetes. Journal of Internal Medicine. 250(1). 81–87. 23 indexed citations
5.
Näslund, Erik, Britta Barkeling, N A King, et al.. (1999). Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.. International Journal of Obesity. 23(3). 304–311. 366 indexed citations
6.
Tolessa, Tesfaye, M. Gutniak, Jens J. Holst, Suad Efendić, & Per M. Hellström. (1998). Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.. Journal of Clinical Investigation. 102(4). 764–774. 114 indexed citations
7.
Tolessa, Tesfaye, M. Gutniak, Jens J. Holst, Suad Efendić, & Per M. Hellström. (1998). Glucagon-like Peptide-1 Retards Gastric Emptying and Small Bowel Transit in the Rat (Effect Mediated Through Central or Enteric Nervous Mechanisms). Digestive Diseases and Sciences. 43(10). 2284–2290. 103 indexed citations
8.
Svartberg, Johan, Jens J. Holst, M. Gutniak, & N. Adner. (1998). The Ethanol Augmentation of Glucose-Induced Insulin Secretion Is Abolished by Calcium Antagonism with Nifedipine. Pancreas. 16(1). 66–71. 11 indexed citations
9.
Näslund, Erik, et al.. (1998). Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. American Journal of Clinical Nutrition. 68(3). 525–530. 242 indexed citations
10.
Åhrén, Bo & M. Gutniak. (1997). No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes. European Journal of Endocrinology. 137(6). 643–649. 11 indexed citations
11.
Gutniak, M., Lisa Juntti‐Berggren, Per M. Hellström, et al.. (1996). Glucagon-Like Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat Pancreas. Diabetes Care. 19(8). 857–863. 64 indexed citations
12.
Ljungqvist, Olle, et al.. (1995). Glucose Infusion Instead of Preoperative Fasting Reduces Postoperative Insulin Resistance. Survey of Anesthesiology. 39(3). 165–165. 87 indexed citations
13.
Gutniak, M., Cathrine Ørskov, Jens J. Holst, Bo Åhrén, & Suad Efendić. (1992). Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus. New England Journal of Medicine. 326(20). 1316–1322. 725 indexed citations breakdown →
14.
Blomqvist, G., Albert Gjedde, M. Gutniak, et al.. (1991). Facilitated transport of glucose from blood to brain in man and the effect of moderate hypoglycaemia on cerebral glucose utilization. European Journal of Nuclear Medicine and Molecular Imaging. 18(10). 834–7. 43 indexed citations
15.
Ljungqvist, Olle, S. Efendić, M. Gutniak, T Häggmark, & Anders Thorell. (1991). Glucose infusion during preoperative fasting reduces postoperative development of insulin resistance. Clinical Nutrition. 10. 27–27. 1 indexed citations
16.
Åhrén, Bo, Magnus Pettersson, Kerstin Uvnäs‐Moberg, M. Gutniak, & Suad Efendić. (1991). Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. Diabetes Research and Clinical Practice. 13(3). 153–161. 44 indexed citations
17.
18.
Östenson, Claes‐Göran, et al.. (1986). Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect. Diabetologia. 29(12). 861–867. 24 indexed citations
19.
Grill, Valdemar, M. Gutniak, Arved Roovete, & Suad Efendić. (1984). A Stimulating Effect of Glucose on Somatostatin Release Is Impaired in Noninsulin-Dependent Diabetes Mellitus*. The Journal of Clinical Endocrinology & Metabolism. 59(2). 293–297. 44 indexed citations
20.
Efendić, Suad, et al.. (1981). Insulin, glucagon and somatostatin in the perfused rat pancreas and the effects of HB 699 (4-(2-(5-chloro-2 metoxy-benzamido)-ethyl)-benzoic acid). European Journal of Endocrinology. 98(4). 573–579. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John W. Ensinck Breakdown of academic impact, for papers by Ole Schmitz Breakdown of academic impact, for papers by Julie A. Lovshin Breakdown of academic impact, for papers by Simon J. Fisher Breakdown of academic impact, for papers by F. P. Alford Breakdown of academic impact, for papers by Erik Frandsen Breakdown of academic impact, for papers by G. Ahlborg Breakdown of academic impact, for papers by Christopher J. Kenyon Breakdown of academic impact, for papers by J. M. Burrin Breakdown of academic impact, for papers by Anna M. Eisentraut
Rankless by CCL
2026